Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Dec 10, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-24-000050.pdf 0001883850-24-000050.xls
Dec 10, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000136.pdf 0001968202-24-000136.xls
Dec 10, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000135.pdf 0001968202-24-000135.xls
Dec 10, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-24-000051.pdf 0001883850-24-000051.xls
Nov 12, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000134.pdf 0001968202-24-000134.xls
Nov 05, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000132.pdf 0001968202-24-000132.xls
Nov 01, 2024	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001950047-24-007992.pdf 0001950047-24-007992.xls
Oct 31, 2024	8-K	Report of unscheduled material events or corporate event	View HTML 0001804220-24-000038.pdf 0001804220-24-000038.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Oct 31, 2024	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001804220-24-000040.pdf 0001804220-24-000040.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Oct 31, 2024	S-3ASR	S-3ASR	View HTML 0001104659-24-113087.pdf 0001104659-24-113087.xls

Data provided by Kaleidoscope.

Investors & Media